Findings from a phase 3 study provided additional evidence that the first pneumococcal vaccine made specifically for adults ...
The FDA has approved lerodalcibep-liga, a third-generation injectable PCSK9 inhibitor, to reduce LDL cholesterol in adults ...
The FDA has qualified AI-Based Histologic Measurement of NASH, or AIM-NASH — the first AI drug development tool — to assist ...
Women who receive risk-based breast cancer screening recommendations discussed those recommendations with their primary care ...
Delivering essential supportive care services during breast cancer treatment lowered stress and improved quality of life for ...
Rafael Kramann, MD, PhD, FASN, FERA, embraced the field of nephrology early in his career for the opportunity to take on ...
Patients with chronic spontaneous urticaria experienced relief in itch and hives by day 3 with povorcitinib, according to ...
Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Courtney Cameron, PharmD, BCACP, about widespread availability of ...
Use of GLP-1 receptor agonists, which have shown to be effective in diabetes and obesity treatment, is expanding into other ...
In patients with diabetes and multivessel coronary artery disease undergoing percutaneous coronary intervention, ticagrelor ...
A new program for training rheumatology fellows at Louisiana State University may offer a new way to combat the specialty’s ...
In this video, Erika Hamilton, MD, discusses HER2CLIMB-05 trial results demonstrating that the addition of tucatinib to maintenance therapy delayed metastatic breast cancer progression for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback